Clinical trials
Completed Observational trials in Zambia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 5 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre for Infectious Disease Research in Zambia | 15 |
| University of North Carolina, Chapel Hill | 11 |
| University of Alabama at Birmingham | 7 |
| NICHD Global Network for Women's and Children's Health | 3 |
| Boston University | 2 |
| COVID-19 Prevention Network | 2 |
| George Washington University | 2 |
| University of Bern | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 10 |
| HIV Infections | 8 |
| Acquired Immunodeficiency Syndrome | 6 |
| COVID-19 | 4 |
| Liver Cirrhosis | 4 |
| HIV Seropositivity | 3 |
| Hepatitis, Alcoholic | 3 |
| Alcoholism | 2 |
| Carcinoma, Hepatocellular | 2 |
| Diarrhea | 2 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.